| 000 | 01523 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515185219.0 | ||
| 264 | 0 | _c20100108 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdp451 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarín, A Pinto | |
| 245 | 0 | 0 |
_aNasal septum perforation in a breast cancer patient treated with bevacizumab. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cNov 2009 |
||
| 300 |
_a1901-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMastectomy |
| 650 | 0 | 4 |
_aNasal Septum _xpathology |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNose Diseases _xchemically induced |
| 650 | 0 | 4 | _aRadiotherapy |
| 700 | 1 | _aSánchez, A Redondo | |
| 700 | 1 | _aArranz, E Espinosa | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 20 _gno. 11 _gp. 1901-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdp451 _zAvailable from publisher's website |
| 999 |
_c19150004 _d19150004 |
||